Results 131 to 140 of about 14,946 (225)

Platelets in angiogenesis and pulmonary progenitor cell homing under chronic intermittent hypoxia. [PDF]

Sci Rep
Demirci Şahin A, Güneş E, Ömercioğlu G, Yozgat AH, Billur D, Baştuğ M.   +5 more
europepmc   +1 more source

The Efficacy and Safety of Endostatin Combined with Definitive Chemoradiotherapy for Unresectable Esophageal Squamous Cell Carcinoma: A Retrospective Analysis. [PDF]

Korean J Gastroenterol
Zhu M, Li Q, Pan X.
europepmc   +1 more source

Anti-angiogenic therapies in cancer: from endogenous inhibitors to bispecific VEGF x PD-(L)1 antibodies. [PDF]

Front Immunol
Álvarez-Vallina L, Sanz L.
europepmc   +1 more source

Identifying new blood biomarkers of neuroplasticity associated with rehabilitation outcomes after stroke. [PDF]

Sci Rep
Garcia-Rodriguez N, Garcia-Gabilondo M, Rodriguez S, Tejada PI, Miranda-Artieda ZM, Ridao N, Buxó X, Pérez-Mesquida ME, Beseler MR, Salom JB, Pérez LM, Inzitari M, Otero-Villaverde S, Martin-Mourelle R, Molleda M, Valor-Blanquer J, Lamana-Vallverdú M, Delgado P, Penalba A, Rosell A.   +19 more
europepmc   +1 more source

Endostatin derivative angiogenesis inhibitors.

Chinese medical journal, 2010
To throw light on the superiority of the anti-angiogenesis activity of endostatin (ES) derivatives by reviewing the recent progress in the field of ES molecular structure modification.The data used in this article were mainly from PubMed with relevant English articles published from 1971 to May 2008. The search terms were "endostatin" and "angiothesis".
openaire   +1 more source

Explainable AI identifies key biomarkers for acute kidney injury prediction in the ICU. [PDF]

Intensive Care Med Exp
Koozi H, Engström J, Friberg H, Frigyesi A.   +3 more
europepmc   +1 more source

Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for driver gene-negative advanced NSCLC: a single-center retrospective real-world study. [PDF]

Front Oncol
Zeng L, Xiang Y, Sun A, Lu K.
europepmc   +1 more source

Endostatin turns heads [PDF]

Nature Medicine, 2002
openaire   +1 more source

Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment. [PDF]

Front Immunol
Sun J, Ren S, Zhao Q, He J, Wang Y, Ren M.   +5 more
europepmc   +1 more source

Editorial: Understanding scleroderma: symptoms, causes, treatment options, and advanced diagnostic techniques. [PDF]

Front Immunol
Ostojic P.
europepmc   +1 more source